주식회사 셀로스바이오텍

{
  "address": "서울 서대문구",
  "ceo_name": "배윤수",
  "certificate": [
    {
      "cert_number": "20190300530",
      "changes": "",
      "disclosure_date": "2019-06-13",
      "first_cert_date": "2019-06-13",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2019-06-13 ~ 2021-06-12"
    },
    {
      "cert_number": "20210714010010",
      "changes": "",
      "disclosure_date": "2021-07-14",
      "first_cert_date": "2019-06-13",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2021-06-13 ~ 2024-06-12"
    },
    {
      "cert_number": "20240521010021",
      "changes": "",
      "disclosure_date": "2024-05-21",
      "first_cert_date": "2019-06-13",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2024-06-13 ~ 2027-06-12"
    }
  ],
  "company_name": "주식회사 셀로스바이오텍",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 72243000,
      "cost_of_sales": 0,
      "current_assets": 405097000,
      "current_liabilities": 469474000,
      "gross_profit": 0,
      "net_income": -2385538000,
      "net_income_bs": -2385538000,
      "non_current_assets": 66610000,
      "non_current_liabilities": 64314000,
      "non_operating_expenses": 991000,
      "non_operating_income": 16752000,
      "operating_profit": -2401299000,
      "revenue": 0,
      "sga_expenses": 2401299000,
      "total_assets": 471707000,
      "total_equity": -62081000,
      "total_liabilities": 533788000
    },
    "2023": {
      "capital_stock": 75855000,
      "cost_of_sales": 0,
      "current_assets": 450497000,
      "current_liabilities": 455244000,
      "gross_profit": 0,
      "net_income": -1074156000,
      "net_income_bs": -1074156000,
      "non_current_assets": 71052000,
      "non_current_liabilities": 265105000,
      "non_operating_expenses": 7116000,
      "non_operating_income": 7062000,
      "operating_profit": -1074102000,
      "revenue": 0,
      "sga_expenses": 1074102000,
      "total_assets": 521549000,
      "total_equity": -198800000,
      "total_liabilities": 720349000
    },
    "2024": {
      "capital_stock": 75855000,
      "cost_of_sales": 0,
      "current_assets": 365507000,
      "current_liabilities": 662559000,
      "gross_profit": 0,
      "net_income": -262334000,
      "net_income_bs": -262334000,
      "non_current_assets": 94272000,
      "non_current_liabilities": 258354000,
      "non_operating_expenses": 20029000,
      "non_operating_income": 6159000,
      "operating_profit": -248464000,
      "revenue": 0,
      "sga_expenses": 248464000,
      "total_assets": 459779000,
      "total_equity": -461134000,
      "total_liabilities": 920913000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,300,041,308",
      "changes": "1,300,041,308",
      "date": "2022-02-23"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-12-24"
    },
    {
      "amount": "500,000,000",
      "changes": "500,000,000",
      "date": "2019-12-24"
    },
    {
      "amount": "999,799,530",
      "changes": "999,799,530",
      "date": "2019-12-24"
    },
    {
      "amount": "500,004,150",
      "changes": "500,004,150",
      "date": "2019-12-24"
    },
    {
      "amount": "1,000,008,300",
      "changes": "1,000,008,300",
      "date": "2019-12-24"
    },
    {
      "amount": "50,042,000",
      "changes": "50,042,000",
      "date": "2019-05-09"
    }
  ],
  "main_products": "의약품 연구 개발",
  "phone": "02-3277-****",
  "years": [
    2024,
    2023,
    2022
  ]
}